Impact of COVID-19 on Liver Transplant Activity in the USA: Variation by Etiology and Cirrhosis Complications.

Yong-Fang KuoPaul KwoRobert J WongAshwani K Singal

Published in: Journal of clinical and translational hepatology (2022)

The COVID-19 pandemic has impacted LT activity, with a decrease of LTs especially for HCC, and an increase of LTs for ALD and severe ACLF. Strategies are needed to reorganize cirrhosis patients to overcome the aftereffects of COVID-19 pandemic.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
respiratory syndrome coronavirus
drug induced